In our latest interview, the Dean of the Jefferson College of Population Health tackles a virtual alphabet soup of current events: the GOP versus the ACA, CVS buying Aetna, the role of PBMs, health care’s slice of the GDP, and the hope (and hype) of CAR T.
New pilot program to evaluate disclosure of clinical study reports
New label includes data on three additional EGFR mutations: L861Q, G719X, and S768I
Vaccine was previously approved for patients older than 3 years of age
Head-to-head study compared Cosentyx and Stelara
Analysts predict peak sales of about $8.2 billion by 2020
Pharmacists call shortage of small-volume parenteral solutions "severe"
First PARP inhibitor to receive FDA approval for use beyond ovarian cancer
CMS issues guidance allowing states to propose programs
Low levels of the mineral are common among women
Society for Healthcare Epidemiology of America provides guidance
Why the Individual Mandate Matters (and Much More) From Dr. David B. Nash
December 2017 interview